FDA grants breakthrough device designation for OBVIUS’ CERTA Access System

The company is preparing for the system’s FDA market clearance submission.

Archana Rani August 27 2024

The US Food and Drug Administration (FDA) has awarded breakthrough device designation for Obvius Robotics’ Certa Access System for central venous catheterisation (CVC).

The hand-held image-guided percutaneous access device aims to standardise and improve the outcomes of these procedures.

Certa is not yet approved for clinical use. Obvius Robotics is actively preparing for its FDA market clearance submission.

Obvius Robotics chief medical officer William Cohn said: “CVC procedures are required for a wide variety of conditions and patients for life-saving care every single day.

“Despite this fact, the procedure still has high complication rates and many health systems lack the expertise to reliably conduct the procedure on critically ill patients in a timely manner. A breakthrough is truly needed to improve care.”

The device makes use of image guidance and precise, targeted needle placement, enabling clinicians to identify target structures such as blood vessels, and rapidly gain access for CVC placement.

Obvius Robotics president and CEO Russell Seiber said: “The goal of Obvius Robotics is to become the new standard of care for CVC access.

“We are excited that the FDA has recognised the potential of the CERTA Access System to be a breakthrough for patients and clinicians. We believe this technology could improve care critical care settings by democratising vascular access procedures.”

In June 2023, Obvius Robotics completed the first in-human study using its CERTA Access System.

The device combines robotics and imaging, allowing clinicians to single-handedly target and access anatomical structures using a targeting system and needle assembly.

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close